Tuberculosis and Respiratory Diseases

The Korean Academy of Tuberculosis and Respiratory Diseases (대한결핵및호흡기학회)
권호 표지
DOI QR코드

DOI QR Code

Simvastatin as a Modulator of Tissue Remodeling through Inhibition of Matrix Metalloproteinase (MMP) Release from Human Lung Fibroblasts

  • Ra, Ji-Eun (Department of Internal Medicine, Wonkwang University Sanbon Hospital, Wonkwang University College of Medicine) ;
  • Lee, Ji-Kyoung (Department of Internal Medicine, Wonkwang University Sanbon Hospital, Wonkwang University College of Medicine) ;
  • Kim, Hui-Jung (Department of Internal Medicine, Wonkwang University Sanbon Hospital, Wonkwang University College of Medicine)
  • Received : 2011.02.24
  • Accepted : 2011.05.17
  • Published : 2011.09.30
Download PDF
⟨ Previous Next ⟩

Abstract

Background: Statins can regulate the production of pro-inflammatory cytokines and inhibit MMP production or activation in a variety of types of cells. This study evaluated whether statins would inhibit MMP release from human lung fibroblasts, which play a major role in remodeling processes. Methods: This study, using an in-vitro model (three-dimensional collagen gel contraction system), evaluated the effect of cytokines (tumor necrosis factor-${\alpha}$, TNF-a and interleukin-$1{\beta}$, IL-1b) on the MMP release and MMP activation from human lung fibroblasts. Collagen degradation induced by cytokines and neutrophil elastase (NE) was evaluated by quantifying hydroxyproline. Results: In three-dimensional collagen gel cultures (3D cultures) where cytokines (TNF-a and IL-1b) can induce the production of MMPs by fibroblasts, it was found that simvastatin inhibited MMP release. In 3D cultures, cytokines together with NE induced collagen degradation and can lead to activation of the MMP, which was inhibited by simvastatin. Conclusion: Simvastatin may play a role in regulating human lung fibroblast functions in repair and remodeling processes by inhibiting MMP release and the conversion from the latent to the active form of MMP.

Keywords

References

  1. Laurell CB. Eriksson S. The electrophoretic alpha;1 globulin pattern of serum in alpha: 1 antitrypsin deficiency. Scand J Clin Lab Invest 1963;15:132-40. https://doi.org/10.1080/00365516309051324
  2. Shapiro SD. The pathogenesis of emphysema: the elastase:antielastase hypothesis 30 years later. Proc Assoc Am Physicians 1995;107:346-52.
  3. Seagrave J. Oxidative mechanisms in tobacco smokeinduced emphysema. J Toxicol Environ Health A 2000; 61:69-78. https://doi.org/10.1080/00984100050116799
  4. Barter MJ, Hui W, Lakey RL, Catterall JB, Cawston TE, Young DA. Lipophilic statins prevent matrix metalloproteinase- mediated cartilage collagen breakdown by inhibiting protein geranylgeranylation. Ann Rheum Dis 2010;69:2189-98. https://doi.org/10.1136/ard.2010.129197
  5. Newton CJ, Ran G, Xie YX, Bilko D, Burgoyne CH, Adams I, et al. Statin-induced apoptosis of vascular endothelial cells is blocked by dexamethasone. J Endocrinol 2002;174:7-16. https://doi.org/10.1677/joe.0.1740007
  6. Elsdale T, Bard J. Collagen substrata for studies on cell behavior. J Cell Biol 1972;54:626-37. https://doi.org/10.1083/jcb.54.3.626
  7. Mio T, Adachi Y, Romberger DJ, Ertl RF, Rennard SI. Regulation of fibroblast proliferation in three-dimensional collagen gel matrix. In Vitro Cell Dev Biol Anim 1996;32:427-33. https://doi.org/10.1007/BF02723005
  8. Gutierrez HH, Pitt BR, Schwarz M, Watkins SC, Lowenstein C, Caniggia I, et al. Pulmonary alveolar epithelial inducible NO synthase gene expression: regulation by inflammatory mediators. Am J Physiol 1995; 268:L501-8.
  9. Bergman I, Loxley R. Two improved and simplified methods for the spectrophotometric determination ofhydroxyproline. Anal Chem 1963;35:1961-5. https://doi.org/10.1021/ac60205a053
  10. Edwards CA, O'Brien WD Jr. Modified assay for determination of hydroxyproline in a tissue hydrolyzate. Clin Chim Acta 1980;104:161-7. https://doi.org/10.1016/0009-8981(80)90192-8
  11. Kleiner DE, Stetler-Stevenson WG. Quantitative zymography: detection of picogram quantities of gelatinases. Anal Biochem 1994;218:325-9. https://doi.org/10.1006/abio.1994.1186
  12. Zhang Y, McCluskey K, Fujii K, Wahl LM. Differential regulation of monocyte matrix metalloproteinase and TIMP-1 production by TNF-alpha, granulocyte-macrophage CSF, and IL-1 beta through prostaglandin-dependent and -independent mechanisms. J Immunol 1998;161:3071-6.
  13. Bell E, Ivarsson B, Merrill C. Production of a tissue-like structure by contraction of collagen lattices by human fibroblasts of different proliferative potential in vitro. Proc Natl Acad Sci USA 1979;76:1274-8. https://doi.org/10.1073/pnas.76.3.1274
  14. Grinnell F. Fibroblasts, myofibroblasts, and wound contraction. J Cell Biol 1994;124:401-4. https://doi.org/10.1083/jcb.124.4.401
  15. Skold CM, Liu X, Umino T, Zhu Y, Ohkuni Y, Romberger DJ. Human neutrophil elastase augments fibroblast- mediated contraction of released collagen gels. Am J Respir Crit Care Med 1999;159:1138-46. https://doi.org/10.1164/ajrccm.159.4.9805033
  16. Zhu YK, Liu XD, Skold CM, Umino T, Wang HJ, Spurzem JR, et al. Synergistic neutrophil elastase-cytokine interaction degrades collagen in three-dimensional culture. Am J Physiol Lung Cell Mol Physiol 2001;281: L868-78. https://doi.org/10.1152/ajplung.2001.281.4.L868
  17. Dans MJ, Isseroff R. Inhibition of collagen lattice contraction by pentoxifylline and interferon-alpha, -beta, and -gamma. J Invest Dermatol 1994;102:118-21. https://doi.org/10.1111/1523-1747.ep12371743
  18. Zhang HY, Gharaee-Kermani M, Phan SH. Regulation of lung fibroblast alpha-smooth muscle actin expression, contractile phenotype, and apoptosis by IL- 1beta. J Immunol 1997;158:1392-9.
  19. Snider GL, Failing LJ, Rennard SI. Chronic bronchitis and emphysema. In: Murray JF, Nadel JA, editors. Texbook of respiratory medicine. 2nd ed. Philadelphia, PA: WB Saunders; 1994. p. 1331-97.
  20. Niewoehner DE. Anatomic and pathophysiological correlations in COPD. In: Baum GL, Crapo JD, Celli BR, Karlinsky JB, editors. Textbook of pulmonary diseases. 6th ed. Philadelphia, PA: Lippincott-Raven; 1998. p. 823-42.
  21. Birkedal-Hansen H, Moore WG, Bodden MK, Windsor LJ, Birkedal-Hansen B, DeCarlo A, et al. Matrix metalloproteinases: a review. Crit Rev Oral Biol Med 1993;4: 197-250.
  22. Woessner JF. The matrix metalloproteinase family. In: Parks WC, Mecham RP, editors. Matrix metalloproteinases. San Diego, CA: Academic Press; 1998. p. 1-13.
  23. Tipton DA, Pabst MJ, Dabbous MK. Interleukin-1 betaand tumor necrosis factor-alpha-independent monocyte stimulation of fibroblast collagenase activity. J Cell Biochem 1990;44:253-64. https://doi.org/10.1002/jcb.240440407
  24. Preaux AM, Mallat A, Nhieu JT, D'Ortho MP, Hembry RM, Mavier P. Matrix metalloproteinase-2 activation in human hepatic fibrosis regulation by cell-matrix interactions. Hepatology 1999;30:944-50.
  25. Ramos-DeSimone N, Hahn-Dantona E, Sipley J, Nagase H, French DL, Quigley JP. Activation of matrix metalloproteinase- 9 (MMP-9) via a converging plasmin/stromelysin- 1 cascade enhances tumor cell invasion. J Biol Chem 1999;274:13066-76. https://doi.org/10.1074/jbc.274.19.13066
  26. Takahashi HK, Mori S, Iwagaki H, Yoshino T, Tanaka N, Weitz-Schmidt G, et al. Differential effect of LFA703, pravastatin, and fluvastatin on production of IL-18 and expression of ICAM-1 and CD40 in human monocytes. J Leukoc Biol 2005;77:400-7. https://doi.org/10.1189/jlb.0904510
  27. Fessler MB, Young SK, Jeyaseelan S, Lieber JG, Arndt PG, Nick JA, et al. A role for hydroxy-methylglutaryl coenzyme a reductase in pulmonary inflammation and host defense. Am J Respir Crit Care Med 2005;171:606- 15. https://doi.org/10.1164/rccm.200406-729OC
  28. Lee JH, Lee DS, Kim EK, Choe KH, Oh YM, Shim TS, et al. Simvastatin inhibits cigarette smoking-induced emphysema and pulmonary hypertension in rat lungs. Am J Respir Crit Care Med 2005;172:987-93. https://doi.org/10.1164/rccm.200501-041OC
  29. Fukumoto Y, Libby P, Rabkin E, Hill CC, Enomoto M, Hirouchi Y, et al. Statins alter smooth muscle cell accumulation and collagen content in established atheroma of watanabe heritable hyperlipidemic rabbits. Circulation 2001;103:993-9. https://doi.org/10.1161/01.CIR.103.7.993
  30. Bellosta S, Via D, Canavesi M, Pfister P, Fumagalli R, Paoletti R, et al. HMG-CoA reductase inhibitors reduce MMP-9 secretion by macrophages. Arterioscler Thromb Vasc Biol 1998;18:1671-8. https://doi.org/10.1161/01.ATV.18.11.1671
  31. Inoue I, Goto S, Mizotani K, Awata T, Mastunaga T, Kawai S, et al. Lipophilic HMG-CoA reductase inhibitor has an anti-inflammatory effect: reduction of MRNA levels for interleukin-1beta, interleukin-6, cyclooxygenase- 2, and p22phox by regulation of peroxisome proliferator-activated receptor alpha (PPARalpha) in primary endothelial cells. Life Sci 2000;67:863-76. https://doi.org/10.1016/S0024-3205(00)00680-9
  32. Ikeda U, Shimpo M, Ohki R, Inaba H, Takahashi M, Yamamoto K, et al. Fluvastatin inhibits matrix metalloproteinase- 1 expression in human vascular endothelial cells. Hypertension 2000;36:325-9. https://doi.org/10.1161/01.HYP.36.3.325
  33. Aikawa M, Rabkin E, Sugiyama S, Voglic SJ, Fukumoto Y, Furukawa Y, et al. An HMG-CoA reductase inhibitor, cerivastatin, suppresses growth of macrophages expressing matrix metalloproteinases and tissue factor in vivo and in vitro. Circulation 2001;103:276-83. https://doi.org/10.1161/01.CIR.103.2.276